Provided by Tiger Trade Technology Pte. Ltd.

Praxis Precision Medicines, Inc.

295.51
+8.603.00%
Post-market: 295.510.00000.00%19:44 EDT
Volume:456.10K
Turnover:134.35M
Market Cap:8.23B
PE:-22.97
High:298.56
Open:290.13
Low:286.00
Close:286.91
52wk High:392.70
52wk Low:50.31
Shares:27.85M
Float Shares:24.08M
Volume Ratio:0.97
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8634
EPS(LYR):-13.4758
ROE:-38.86%
ROA:-25.65%
PB:6.14
PE(LYR):-21.93

Loading ...

Wedbush Adjusts PT on Praxis Precision Medicines to $188 From $162, Maintains Underperform Rating

MT Newswires Live
·
Aug 06

Movement Alert|Praxis Precision Medicines, Inc. Rises 16.43% in Regular Trading, Q2 Earnings and Pipeline Catalysts Drive Surge

Market Focus
·
Aug 06

Praxis Precision Medicines, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Stock Track | Praxis Precision Medicines Soars 14.56% Intraday on Q2 Earnings Beat and Positive FDA Pipeline Updates

Stock Track
·
Aug 06

Praxis Q2 2026 results: $1.4 billion liquidity supports runway into 2028

TradingKey
·
Aug 06

Praxis Precision Medicines Posts Investor Deck Highlighting Late-Stage CNS Pipeline, Upcoming PDUFA Dates

Reuters
·
Aug 06

Stock Track | Praxis Precision Medicines Soars 5.88% in Pre-market on Q2 Earnings Beat and Upbeat Pipeline Progress

Stock Track
·
Aug 06

Praxis Precision Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 06

Praxis Precision Net Loss Widens 17.7% to $83.72 Million in Q2 FY26

Reuters
·
Aug 06

Earnings Flash (PRAX) Praxis Precision Medicines Posts Q2 Loss $2.87 a Share, vs. FactSet Est of $3.64 Loss

MT Newswires Live
·
Aug 06

Praxis Precision Medicine Q2 EPS $(2.87) Beats $(3.65) Estimate

Benzinga Earnings
·
Aug 06

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 06

Praxis Precision Q2 EPS USD -2.87

THOMSON REUTERS
·
Aug 06

Praxis Precision Q2 Operating Expenses USD 96.904 Million

THOMSON REUTERS
·
Aug 06

Praxis Precision Medicines Grants 7,318 RSUs to 29 New Employees Under 2024 Inducement Plan

Reuters
·
Aug 05

Praxis Precision Medicines, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 05

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 05

Praxis Precision Medicines Inc Expected to Post a Loss of $3.66 a Share - Earnings Preview

Reuters
·
Aug 04

Praxis Extends Vormatrogine Epilepsy Trial, Keeping Long-Term Growth Story in Play

TIPRANKS
·
Aug 04

Praxis Advances PRAX-628 Tablet Formulation in Completed Bioavailability Study

TIPRANKS
·
Aug 04